Found: 3
Select item for more details and to access through your institution.
P4-362: Tarenflurbil clearance is not reduced in subjects with mild or moderate hepatic impairment
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-395: Inhibition of CYP2C9 by fluconazole reduces clearance and increases exposure to tarenflurbil
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-383: Tarenflurbil (MPC-7869), a selective Aβ42-lowering agent, has no significant effect on the pharmacokinetics and pharmacodynamics of warfarin
- Published in:
- 2008
- By:
- Publication type:
- Abstract